TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32150297

Group type: EXPERIMENTAL
Intervention: Bortezomib maintenance (1·3 mg/m2 intravenously once every 2 weeks, for 2 years)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 60
Study: 34402959

Group type: EXPERIMENTAL
Intervention: SADI-GP (pylorus-preserving single-anastomosis duodeno-ileal bypass with gastric plication)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: SADI-GP
Number of subjects: 17
Study: 32434454

Group type: EXPERIMENTAL
Intervention: Upper limb robotic training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Occupational therapy
Number of subjects: 50
Study: 35729612

Group type: EXPERIMENTAL
Intervention: Community delivery of IPTp by community health workers
Number of subjects: 1057

Group type: COMPARATOR
Intervention: Control group receiving IPTp at health facilities
Number of subjects: 1057
Study: 32140428

Group type: EXPERIMENTAL
Intervention: Diabetes prevalence assessment
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Awareness of diabetes
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Hypertension prevalence among diabetics
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Factors associated with diabetes
Number of subjects: 634
Study: 34626001

Group type: EXPERIMENTAL
Intervention: Nurse-led comprehensive geriatric assessment (CGA)-based intervention
Number of subjects: 33
Study: 33755863

Group type: EXPERIMENTAL
Intervention: Zolbetuximab plus EOX (ZOL/EOX)
Number of subjects: 143

Group type: COMPARATOR
Intervention: EOX alone
Number of subjects: 143
Study: 33107002

Group type: EXPERIMENTAL
Intervention: High coaching group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low coaching group
Number of subjects: 40
Study: 35006086

Group type: EXPERIMENTAL
Intervention: Digital delivery of audit and feedback intervention
Number of subjects: 2552

Group type: COMPARATOR
Intervention: Postal delivery of audit and feedback intervention
Number of subjects: 2552

Group type: COMPARATOR
Intervention: Comparison of digital vs postal delivery
Number of subjects: 2552
Study: 33472650

Group type: EXPERIMENTAL
Intervention: Provider-directed intervention (monetary incentive for mRDT performance)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Client-directed intervention (free ACT for positive mRDT)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Combined provider- and client-directed interventions
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 89
Study: 32280042

Group type: EXPERIMENTAL
Intervention: 1-week, 4-site intradermal (ID) rabies vaccination without ERIG (Group 1)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: 1-week, 4-site intradermal (ID) rabies vaccination with ERIG (Group 2)
Number of subjects: 397

Group type: COMPARATOR
Intervention: 28-day, 2-site (2-2-2-0-2) ID regimen with ERIG (Group 3)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Simulated PEP vaccination at Year 5
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: 1-week, 4-site ID regimen with PVRV
Number of subjects: 397
Study: 36208719

Group type: EXPERIMENTAL
Intervention: FAMS 2.0 (mobile phone-delivered intervention including phone coaching and text message support)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (control)
Number of subjects: 338
Study: 35441849

Group type: EXPERIMENTAL
Intervention: Lower oxygenation target (8 kPa)
Number of subjects: 2928

Group type: COMPARATOR
Intervention: Higher oxygenation target (12 kPa)
Number of subjects: 2928
Study: 612365097

Group type: EXPERIMENTAL
Intervention: ONO-9054 (0.003%, 30 mug/mL) once daily for 28 days
Number of subjects: 123

Group type: COMPARATOR
Intervention: Xalatan (0.005%, 50 mug/mL) once daily for 28 days
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ONO-9054
Number of subjects: 123
Study: 35373861

Group type: EXPERIMENTAL
Intervention: Waterbirth
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Nonwaterbirth
Number of subjects: 1260
Study: 33711380

Group type: EXPERIMENTAL
Intervention: 15 mg intravitreal pegcetacoplan
Number of subjects: 246

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 246
Study: 32757523

Group type: EXPERIMENTAL
Intervention: Ofatumumab
Number of subjects: 1882

Group type: COMPARATOR
Intervention: Teriflunomide
Number of subjects: 1882
Study: 34525247

Group type: EXPERIMENTAL
Intervention: Pre‐emptive 800mg of intravenous ibuprofen plus 1000mg of intravenous paracetamol (Group IP)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Only 1000mg of intravenous paracetamol (Group P)
Number of subjects: 69
Study: 33242754

Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg, days 1–4)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 35272114

Group type: EXPERIMENTAL
Intervention: GLIM criteria
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: PG-SGA
Number of subjects: 468
Study: 34386279

Group type: EXPERIMENTAL
Intervention: Perturbation-based NM training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 32558305

Group type: EXPERIMENTAL
Intervention: topical nepafenac (1 mg/ml) 1 drop 3 times per day for 3 days before surgery
Number of subjects: 73

Group type: COMPARATOR
Intervention: not receiving topical nepafenac (control group)
Number of subjects: 73
Study: 35697571

Group type: EXPERIMENTAL
Intervention: Single booster dose of 4CMenB in the infant + preschool group
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Single booster dose of 4CMenB in the infant group
Number of subjects: 2

Group type: COMPARATOR
Intervention: Two doses of 4CMenB in naïve age-matched controls (adolescent 2 group)
Number of subjects: 2
Study: 32445881

Group type: EXPERIMENTAL
Intervention: Combined group (Arbidol and IFN-α2b)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Monotherapy group (IFN-α2b inhalation for 10–14 days)
Number of subjects: 141
Study: 36442480

Group type: EXPERIMENTAL
Intervention: Frankincense-based herbal product (FHP)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Solifenacin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33640917

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 457
Study: 33355268

Group type: EXPERIMENTAL
Intervention: Indashyikirwa programme (21-session curriculum)
Number of subjects: 1654

Group type: COMPARATOR
Intervention: VSLA as usual (control)
Number of subjects: 1654
Study: 33541815

Group type: EXPERIMENTAL
Intervention: 2% Olive Leaf Extract (OLE) cream
Number of subjects: 66

Group type: COMPARATOR
Intervention: 5% Acyclovir cream
Number of subjects: 66
Study: 32851775

Group type: EXPERIMENTAL
Intervention: FOVEA program (8 weeks, 2 hours/week)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Wait-list group
Number of subjects: 139
Study: 35816621

Group type: EXPERIMENTAL
Intervention: Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 33411233

Group type: EXPERIMENTAL
Intervention: Child-Parent Psychotherapy (CPP)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (DC)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Non-depressed comparison group (NC)
Number of subjects: 198
Study: 34328264

Group type: EXPERIMENTAL
Intervention: Sonic brushing (SB)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Manual brushing (MB)
Number of subjects: 32
Study: 32683737

Group type: EXPERIMENTAL
Intervention: WeClick mobile phone application (4-week access)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Wait list control (4-week wait)
Number of subjects: 193
Study: 36004391

Group type: EXPERIMENTAL
Intervention: Low Carbohydrate Diet (LCD)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Standard Carbohydrate Diet (SCD)
Number of subjects: 39

Group type: COMPARATOR
Intervention: General diabetes education (Control)
Number of subjects: 39
Study: 34106237

Group type: EXPERIMENTAL
Intervention: Sustained Care Smoking Cessation Intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis including unit as a covariate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Missing equated to smoking
Number of subjects: 0
Study: 32987892

Group type: EXPERIMENTAL
Intervention: Anthocyanin intake
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 249

Group type: COMPARATOR
Intervention: Low anthocyanin intake and low physical activity
Number of subjects: 249
Study: 35315226

Group type: EXPERIMENTAL
Intervention: Description condition (problem framing: gain/loss)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Experience condition (problem framing: gain/loss)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: General problem framing
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Specific problem framing
Number of subjects: 320
Study: 32681665

Group type: EXPERIMENTAL
Intervention: VL50
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: VL15
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: VL0
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: VL25 and VL50
Number of subjects: 64
Study: 34936990

Group type: EXPERIMENTAL
Intervention: Group visit intervention (GV)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study: 32908283

Group type: EXPERIMENTAL
Intervention: AI intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 35681220

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN) initiated < 48 hours from ICU admission
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 626

Group type: COMPARATOR
Intervention: Delayed enteral nutrition (DEN) initiated > 48 hours from ICU admission
Number of subjects: 626

Group type: COMPARATOR
Intervention: Delayed enteral nutrition (DEN)
Number of subjects: 626
Study: 34967353

Group type: EXPERIMENTAL
Intervention: nano-modified Runji ointment
Number of subjects: 80

Group type: COMPARATOR
Intervention: placebo ointment
Number of subjects: 80
Study: 33916877

Group type: EXPERIMENTAL
Intervention: High Protein (HP) hypercaloric diet
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Normal Protein (NP) hypercaloric diet
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control Diet (CD)
Number of subjects: 17
Study: 33320267

Group type: EXPERIMENTAL
Intervention: Peer-to-peer (P2P) support
Number of subjects: 448

Group type: COMPARATOR
Intervention: Standard community services (SCS)
Number of subjects: 448
Study: 36117205

Group type: EXPERIMENTAL
Intervention: Dietary Insulin Load (DIL) highest quartile
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Dietary Insulin Load (DIL) highest quartile, adjusted for confounders
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Dietary Insulin Load (DIL) highest quartile, further adjusted for BMI
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Dietary Insulin Index (DII)
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Dietary Insulin Load (DIL)
Number of subjects: 10000
Study: 32563846

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone treatment
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Mutual-help group participation
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Lifetime major depressive disorder
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Goal of opioid abstinence at treatment entry
Number of subjects: 360
Study: 33455926

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside (IIM) 20 mg/kg
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) intravenously at inclusion and topically during surgery
Number of subjects: 780

Group type: COMPARATOR
Intervention: Placebo for iron isomaltoside (IIM)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Placebo for tranexamic acid (TXA)
Number of subjects: 780
Study: 33036579

Group type: EXPERIMENTAL
Intervention: HDR‐BT + hypofractionated WPRT (25 Gy in 5 fractions)
Number of subjects: 58

Group type: COMPARATOR
Intervention: HDR‐BT + conventionally fractionated WPRT (45 Gy in 25 fractions)
Number of subjects: 58
Study: 35989346

Group type: EXPERIMENTAL
Intervention: Diltiazem 30 mg every 12 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 40
Study: 34125135

Group type: EXPERIMENTAL
Intervention: Brief cessation advice, a 1-week free sample of nicotine replacement therapy (NRT), and active referral to a community-based smoking cessation service.
Number of subjects: 1053

Group type: COMPARATOR
Intervention: Brief cessation advice with a leaflet on hazards of perinatal exposure to tobacco smoke and the toll-free quitline telephone number.
Number of subjects: 1053
Study: 32242145

Group type: EXPERIMENTAL
Intervention: Mindfulness training (8-week course)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Mental health support as usual (control)
Number of subjects: 54
Study: 36279236

Group type: EXPERIMENTAL
Intervention: Neodolpasse (30 mg Orphenadrine and 75 mg Diclofenac)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with Morphine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Neodolpasse
Number of subjects: 20

Group type: COMPARATOR
Intervention: PCA with Morphine
Number of subjects: 20
Study: 34959784

Group type: EXPERIMENTAL
Intervention: Traditional Atlantic diet intervention (educational sessions, cooking classes, written material, and foods)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (habitual lifestyle)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Changes in bodyweight per unit increment of 'Frieds' score
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Changes in bodyweight per unit increment of 'Fruits, vegetables, and dairy products' score
Number of subjects: 250
Study: 32727835

Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR) 600 mg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (interferon beta or no disease-modifying therapy)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR2 group)
Number of subjects: 102
Study: 34592768

Group type: EXPERIMENTAL
Intervention: Experimental endotracheal tube (ETT) with color scale
Number of subjects: 108

Group type: COMPARATOR
Intervention: Numeric endotracheal tube (ETT) scale
Number of subjects: 108
Study: 33881710

Group type: COMPARATOR
Intervention: O group (warm environment)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: P group (passive acclimation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: A group (active acclimation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: CTRL group (comfortable conditions)
Number of subjects: 40
Study: 32641340

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (enteral nutrition with reduced carbohydrates)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard enteral nutrition (control)
Number of subjects: 0
Study: 35669738

Group type: EXPERIMENTAL
Intervention: ONLINE (interactive web-based weight loss program)
Number of subjects: 92

Group type: COMPARATOR
Intervention: CON (non-interactive web-based weight loss program)
Number of subjects: 92
Study: 34652087

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (12 weeks, 3-4 sessions per week, 30-60 minutes)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no change in physical activity)
Number of subjects: 29
Study: 34894702

Group type: EXPERIMENTAL
Intervention: Periarticular infiltration (PAI) with 100 mL cocktail solution (ropivacaine 20 mL, ketorolac 2 mL, epinephrine 1 mL mixed with normal saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pericapsular nerve group (PENG) block with 30 mL of 0.5% ropivacaine
Number of subjects: 60
Study: 34118411

Group type: EXPERIMENTAL
Intervention: Electrospun fibers of amorphous solid dispersion (ASD) of itraconazole and poly(vinylpyrrolidone‐co‐vinyl acetate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous processing of milled drug‐loaded electrospun materials to tablet form
Number of subjects: 0
Study: 35272318

Group type: EXPERIMENTAL
Intervention: Anchor-based device
Number of subjects: 43

Group type: COMPARATOR
Intervention: Suture-capturing device
Number of subjects: 43
Study: 33896388

Group type: EXPERIMENTAL
Intervention: Mg + B vitamins + green tea + rhodiola
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mg + B vitamins + rhodiola
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mg + B vitamins + green tea
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32174625

Group type: EXPERIMENTAL
Intervention: Customized oral health educational video (Group A)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Sign language (Group B)
Number of subjects: 68
Study: 33475748

Group type: EXPERIMENTAL
Intervention: HLA epitope‐matched (HEM) platelet transfusions
Number of subjects: 0

Group type: COMPARATOR
Intervention: HLA standard antigen‐matched (HSM) platelet transfusions
Number of subjects: 0
Study: 35006001

Group type: EXPERIMENTAL
Intervention: mHealth intervention (AppAlone)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: mHealth intervention+coaching (AppCoach)
Number of subjects: 117

Group type: COMPARATOR
Intervention: in‐person intervention (Control)
Number of subjects: 117
Study: 35341666

Group type: EXPERIMENTAL
Intervention: Cytokine hemoadsorber integrated into the cardiopulmonary bypass circuit
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no cytokine hemoadsorber)
Number of subjects: 19
Study: 32419038

Group type: EXPERIMENTAL
Intervention: Surgical resection with margin-negative resection and regional lymphadenectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy strategies
Number of subjects: 0
Study: 35293844

Group type: EXPERIMENTAL
Intervention: Acute exercise (high-intensity, low-intensity, moderate-intensity, treadmill jogging, cycling, racquetball)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Select exercise modalities (e.g. treadmill exercise)
Number of subjects: 0
Study: 34349379

Group type: COMPARATOR
Intervention: Fentanyl patch 25 μg·h‐1
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Buprenorphine patch 10 μg·h‐1
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Buprenorphine patch 20 μg·h‐1
Number of subjects: 150
Study: 35921797

Group type: EXPERIMENTAL
Intervention: Reshaping group (closure of excision defect with mobilised breast tissue)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Control group (no attempt at defect closure)
Number of subjects: 233
Study: 34472600

Group type: EXPERIMENTAL
Intervention: Children's sleep quality during COVID-19 pandemic
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Factors contributing to sleep changes
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Disrupted routines
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: eHealth interventions (BNBD)
Number of subjects: 85
Study: 35179742

Group type: EXPERIMENTAL
Intervention: Risk score based on five independent predictors of no-reflow (NRF)
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Independent predictors of NRF: age ≥ 65 years (OR: 2.473, p < 0.01), heart rate ≥ 89 bpm (OR: 1.622, p < 0.05), Killip class ≥ II (OR: 1.914, p < 0.01), total ischemic time ≥ 268 min (OR: 2.652, p < 0.01), thrombus burden G≥4 (OR: 8.351, p < 0.01)
Number of subjects: 1254
Study: 32897568

Group type: EXPERIMENTAL
Intervention: ECC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CON-ECC
Number of subjects: 30

Group type: COMPARATOR
Intervention: CTRL
Number of subjects: 30
Study: 36451454

Group type: EXPERIMENTAL
Intervention: EPIAO®
Number of subjects: 200

Group type: COMPARATOR
Intervention: EPREX®
Number of subjects: 200
Study: 34009291

Group type: EXPERIMENTAL
Intervention: Perioperative systemic therapy (CAPOX, FOLFOX, or FOLFIRI)
Number of subjects: 79

Group type: COMPARATOR
Intervention: CRS‐HIPEC alone (control)
Number of subjects: 79
Study: 32790108

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 3620

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3620
Study: 35353246

Group type: EXPERIMENTAL
Intervention: Urethral mid‐point Foley catheter measurement (FCM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual surgical care (no Foley catheter measurement, no‐FCM)
Number of subjects: 44
Study: 33589320

Group type: EXPERIMENTAL
Intervention: Wholegrain enriched diet
Number of subjects: 54

Group type: COMPARATOR
Intervention: Refined-wheat cereals diet (control diet)
Number of subjects: 54
Study: 34414835

Group type: EXPERIMENTAL
Intervention: Zip‐stitch clips
Number of subjects: 27

Group type: COMPARATOR
Intervention: VICRYL sutures
Number of subjects: 27
Study: 33612600

Group type: EXPERIMENTAL
Intervention: Non-invasive BGL Measurement Optical Device (NI-BGL-MOD)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Reference standard: venipuncture spectrophotometry
Number of subjects: 110
Study: 35219336

Group type: EXPERIMENTAL
Intervention: Continuous Care Model (CCM) using a smartphone application
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study: 34146140

Group type: EXPERIMENTAL
Intervention: Image-guided interventional procedures around the hip
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Expert consensus
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Evidence level for statements
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Consensus strength
Number of subjects: 53
Study: 32761844

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 342

Group type: COMPARATOR
Intervention: Relaxation control
Number of subjects: 342
Study: 36001429

Group type: COMPARATOR
Intervention: Alcohol administration (intravenous clamping procedure to achieve a breath alcohol concentration of 0.05% maintained over 3 hours)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Self-administered alcohol (intravenous)
Number of subjects: 70
Study: 34463420

Group type: COMPARATOR
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dulaglutide 3.0 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dulaglutide 4.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dulaglutide 3.0 mg and 4.5 mg
Number of subjects: 0
Study: 35481935

Group type: EXPERIMENTAL
Intervention: Portable air cleaners (PACs) with HEPA filters
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham (filter removed)
Number of subjects: 17
Study: 33857011

Group type: EXPERIMENTAL
Intervention: Withings ScanWatch
Number of subjects: 14